^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    drebuxelimab (AK119)

    i
    Associations
    News

    Trials

    Company:
    Akesobio
    Drug class:
    CD73 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Study of AK119 and AK 112 With or Without Chemotherapy for Colorectal Cancer Patients (NCT05846867)
    Phase 1/2
    Akeso
    Not yet recruiting
    Last update posted :
    05/08/2023
    Initiation :
    05/10/2023
    Primary completion :
    05/10/2024
    Completion :
    07/10/2025
    MLH1 • MSH6 • MSH2
    |
    PD-L1 expression • MSH6 expression
    |
    5-fluorouracil • oxaliplatin • irinotecan • leucovorin calcium • Yidafan (ivonescimab) • drebuxelimab (AK119)